Report Overview

A rising prevalence of diabetes, increasing adoption of technological advancements, and growing awareness about and emphasis on early diabetes management are expected to drive India Blood Glucose Monitoring Devices Market during the forecast period between 2024 and 2030.

India Blood Glucose Monitoring Devices Market – Industry Trends & Forecast Report, 2030

India Blood Glucose Monitoring Devices Market size by value was estimated at USD 335.76 million in 2023. During the forecast period between 2024 and 2030, India Blood Glucose Monitoring Devices Market size is projected to grow at a CAGR of 7.32% reaching a value of USD 582.51 million by 2030. A prominent driver of the market is the rising prevalence of diabetes mellitus in India, which has become increasingly critical due to its impact during the COVID-19 pandemic. The growing elderly population, a demographic more susceptible to diabetes, further fuels market expansion.

By volume, India Blood Glucose Monitoring Devices Market size was estimated at 187.2 million strips in 2023. During the forecast period between 2024 and 2030, India Blood Glucose Monitoring Devices Market size is projected to grow at a CAGR of 7.26% reaching the volume of 256.6 million strips by 2030. Heightened awareness about preventive healthcare and the growing trend toward sedentary lifestyles in urban areas are also major contributing factors the market growth. The significant rise in the number of patients with both Type 1 and Type 2 diabetes, particularly insulin-dependent cases, necessitates advanced monitoring systems, are expected to significantly boost the growth of Indian Blood Glucose Monitoring Devices Market during the period in analysis.

Blood Glucose Monitoring Devices – Overview

Blood glucose monitoring devices are medical tools used to measure and monitor the levels of glucose (sugar) in the blood. These devices are essential for individuals with diabetes mellitus, a condition characterized by elevated blood sugar levels. Monitoring devices typically include glucose meters and continuous glucose monitoring (CGM) systems. Glucose meters analyze a small blood sample obtained from a finger prick to provide real-time glucose readings. CGM systems use sensors inserted under the skin to continuously monitor glucose levels, providing ongoing data to users. Both types of devices play a critical role in diabetes management by helping patients and healthcare providers track blood sugar levels, adjust treatment plans, and maintain optimal health.

India Blood Glucose Monitoring Devices Market

Growth Drivers

Rising Prevalence of Diabetes

The increasing prevalence of diabetes in India has propelled significant growth in the market for blood glucose monitoring devices. With approximately 80 million diabetics, India ranks second globally in terms of diabetic population, underscoring the urgent need for effective disease management tools. This rise is not confined to urban centers but extends to rural areas as well, driven by lifestyle changes and increasing health awareness. The COVID-19 pandemic further emphasized the critical role of monitoring devices in managing diabetes and mitigating associated risks. As a result, there has been a heightened demand for advanced technologies that can accurately track and manage blood glucose levels. This trend presents substantial market opportunities, encouraging innovation and expansion within India's blood glucose monitoring devices sector.

Challenges

High Cost of Blood Glucose Monitoring Devices

The high cost of glucose monitoring devices poses a significant barrier to the growth of India Blood Glucose Monitoring Devices Market. Affordability remains a key concern, particularly in a country where healthcare expenses can be prohibitive for a large segment of the population. The cost factor limits widespread adoption, especially in rural areas where economic constraints are more pronounced. Addressing this challenge through innovations in cost-effective technologies and broader accessibility initiatives will be crucial to expanding market penetration and improving diabetes management nationwide.

Impact of Escalating Geopolitical Tensions on India Blood Glucose Monitoring Devices Market

Escalating geopolitical tensions among countries across regions could have a significant impact on the growth of India Blood Glucose Monitoring Devices Market. Manufacturers heavily reliant on international components may face challenges in sourcing materials, leading to potential supply shortages and price fluctuations. Moreover, geopolitical instability can dampen investor confidence and hinder market growth initiatives. To mitigate these impacts, local manufacturing capabilities and diversified supply chains can offer resilience. Additionally, strategic partnerships and regulatory measures aimed at stabilizing trade relations can help mitigate risks and sustain market stability for blood glucose monitoring devices in India.

India Blood Glucose Monitoring Devices Market

Segmental Coverage

India Blood Glucose Monitoring Devices Market – By Devices

On the basis of devices, India Blood Glucose Monitoring Devices Market is split into Self-monitoring Blood Glucose and Continuous Blood Glucose Monitoring Devices segments. The continuous blood glucose monitoring devices segment is expected to hold a higher share in India Blood Glucose Monitoring Devices Market by devices over the forecast period, due to its advanced capabilities in providing real-time and continuous glucose level monitoring. CGM systems offer users immediate insights into glucose fluctuations, aiding in proactive diabetes management and reducing the need for frequent finger-prick testing. This technology is increasingly preferred by patients seeking convenience and improved accuracy in glucose monitoring. As awareness grows and technological advancements enhance CGM reliability and affordability, this segment is expected to capture a larger market share, catering to the rising demand for effective diabetes management solutions in India. Also, the continuous blood glucose monitoring devices segment includes sensors and durables (receivers and transmitters).

India Blood Glucose Monitoring Devices Market – By End User

Based on end user, India Blood Glucose Monitoring Devices Market is bifurcated into Hospital/ Clinical Usage and Home/Personal Usage segments. The trend is driven by increasing patient preference for self-monitoring devices at home, which provide convenience and empowerment. Technological improvements have enhanced these devices, making them more user-friendly with intuitive interfaces and seamless integration with smartphones and other devices. The COVID-19 pandemic has accelerated the adoption of remote patient monitoring, underscoring the critical role of home care settings in ensuring continuous and efficient healthcare services.

India Blood Glucose Monitoring Devices Market – By Region

Geographically, India Blood Glucose Monitoring Devices Market is divided into North India, South India, East India, and West India regions. West India leads India Blood Glucose Monitoring Devices Market and is also expected to maintain its dominance during the period in analysis. The region's expanding healthcare facilities, increasing affluence among residents, and rising awareness regarding diabetes care. Major urban centers such as Mumbai and Pune play pivotal roles as centers for diagnosing, treating, and managing diabetes, bolstering continuous market expansion in the area.

Competitive Landscape

Major players operating in India Blood Glucose Monitoring Devices Market include Abbott Diabetes Care, Roche Diabetes Care, LifeScan, Dexcom Inc, Medtronic PLC, Arkray Inc, Ascensia Diabetes Care, Agamatrix Inc, and Trivida Health. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In June 2024 - Beurer GmbH announced its plans to launch a new Blood Glucose Monitor Device by September/October 2024. The company also plans comprehensive health education programs, including community outreach and collaborations with healthcare professionals, underscoring its commitment to advancing health monitoring awareness in India.

• In May 2024 - Roche Diabetes Care India shifted production of the 'Accu-Chek Active' blood glucose monitoring device to Chennai, India, in collaboration with Sanmina-SCI India Pvt Ltd and Parekh Integrated Services Pvt Ltd. This move aims to enhance accessibility for diabetes care in India by reducing time to market and displaying the 'Made in India' label on product packs.

Scope of the Report

By Devices

• Self-Monitoring Blood Glucose Devices  

• Continuous Blood Glucose Monitoring Devices  

By End User

• Hospital/Clinical Usage 

• Home/Personal Usage

By Region

• North India

• South India

• East India

• West India